Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benedikt Winter

Showing results (11-20 of 29) with videos related to

Pageof 3
Sort By:
Faraday Discussions|April 23, 2021
Renewable carbon feedstock for polymers: environmental benefits from synergistic use of biomass and CO<sub>2</sub>Marvin Bachmann, Arne Kätelhön, Benedikt Winter, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|January 12, 2019
Neurofilaments and tau in CSF in an infant with SMA type 1 treated with nusinersenBenedikt Winter, René Guenther, Albert Christian Ludolph, et al.
Science (New York, N.Y.)|September 30, 2021
Achieving net-zero greenhouse gas emission plastics by a circular carbon economyRaoul Meys, Arne Kätelhön, Marvin Bachmann, et al.
Iscience|August 9, 2023
Blue and green ammonia production: A techno-economic and life cycle assessment perspectivePatricia Mayer, Adrian Ramirez, Giuseppe Pezzella, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|June 22, 2021
NR4A2 and Dystonia with Dopa ResponsivenessBenedikt Winter, Johannes Krämer, Tamara Meinhardt, et al.
Archives of Disease in Childhood. Fetal and Neonatal Edition|November 24, 2025
Reduction of IVH in very preterm infants via a two-step quality improvement project: a retrospective study of 14 years' experienceJochen Essers, Manuel Boris Bryant, Cornelia Horsch, et al.
Frontiers in Neurology|April 15, 2021
Quality of Life in SMA Patients Under Treatment With NusinersenLucas Mix, Benedikt Winter, Claudia D Wurster, et al.
Journal of Neurology|November 22, 2018
Intrathecal administration of nusinersen in adolescent and adult SMA type 2 and 3 patientsClaudia D Wurster, Benedikt Winter, Kurt Wollinsky, et al.
Arzneimittel-Forschung|September 4, 2004
Efficacy of ivermectin in a patient population concomitantly infected with intestinal helminths and ectoparasitesJörg Heukelbach, Thomas Wilcke, Benedikt Winter, et al.
Frontiers in Neurology|January 1, 2024
Paradoxical increase of neurofilaments in SMA patients treated with onasemnogene abeparvovec-xioiMarina Flotats-Bastardas, Lisa Bitzan, Charlotte Grell, et al.
Pageof 3

Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
Faraday Discussions|April 23, 2021
Renewable carbon feedstock for polymers: environmental benefits from synergistic use of biomass and CO<sub>2</sub>Marvin Bachmann, Arne Kätelhön, Benedikt Winter, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|January 12, 2019
Neurofilaments and tau in CSF in an infant with SMA type 1 treated with nusinersenBenedikt Winter, René Guenther, Albert Christian Ludolph, et al.
Science (New York, N.Y.)|September 30, 2021
Achieving net-zero greenhouse gas emission plastics by a circular carbon economyRaoul Meys, Arne Kätelhön, Marvin Bachmann, et al.
Iscience|August 9, 2023
Blue and green ammonia production: A techno-economic and life cycle assessment perspectivePatricia Mayer, Adrian Ramirez, Giuseppe Pezzella, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|June 22, 2021
NR4A2 and Dystonia with Dopa ResponsivenessBenedikt Winter, Johannes Krämer, Tamara Meinhardt, et al.
Archives of Disease in Childhood. Fetal and Neonatal Edition|November 24, 2025
Reduction of IVH in very preterm infants via a two-step quality improvement project: a retrospective study of 14 years' experienceJochen Essers, Manuel Boris Bryant, Cornelia Horsch, et al.
Frontiers in Neurology|April 15, 2021
Quality of Life in SMA Patients Under Treatment With NusinersenLucas Mix, Benedikt Winter, Claudia D Wurster, et al.
Journal of Neurology|November 22, 2018
Intrathecal administration of nusinersen in adolescent and adult SMA type 2 and 3 patientsClaudia D Wurster, Benedikt Winter, Kurt Wollinsky, et al.
Arzneimittel-Forschung|September 4, 2004
Efficacy of ivermectin in a patient population concomitantly infected with intestinal helminths and ectoparasitesJörg Heukelbach, Thomas Wilcke, Benedikt Winter, et al.
Frontiers in Neurology|January 1, 2024
Paradoxical increase of neurofilaments in SMA patients treated with onasemnogene abeparvovec-xioiMarina Flotats-Bastardas, Lisa Bitzan, Charlotte Grell, et al.
Pageof 3